Skip to main content
NVDA-1.44%AAPL+1.26%GOOGL+0.85%MSFT-0.21%AMZN-0.15%TSM-1.43%SPCX-2.37%META-1.43%AVGO-1.85%TSLA-2.60%LLY+3.76%BRK-B-0.30%SKHY-3.54%MU-1.09%AMD-2.92%WMT+1.78%JPM-0.26%V-0.45%XOM+0.62%ASMLa+1.88%JNJ+0.81%MA-0.10%INTC-1.89%ABBV+2.31%0700.HK-0.42%1398.HK-0.92%CSCO+0.27%CVX+1.02%COST+1.13%KO+0.67%ORCL-6.65%PG+1.14%LRCX-2.85%AMAT-2.50%AP2d+0.04%UNH+3.63%BAC-8.01%DELL-7.35%CAT-1.04%1816.HK+2.71%3988.HK-1.12%0005.HK-1.79%0857.HK+1.17%HSBA.L-1.35%GE+0.47%PM+1.45%0939.HK-1.00%1288.HK-2.23%NFLX+0.41%HD-0.72%USDCHF+1.02%USDSEK+1.00%USDMXN+0.95%CADCHF+0.80%USDZAR+0.76%AUDCHF+0.74%EURUSD-0.71%USDDKK+0.69%EURHKD-0.68%USDPLN+0.64%GBPCHF+0.64%CHFJPY-0.62%EURCNH-0.59%NZDUSD-0.58%USDTHB+0.52%EURCAD-0.50%USDSGD+0.50%EURAUD-0.42%GBPTRY+0.41%AUDDKK+0.41%USDNOK+0.41%NZDCHF+0.41%GBPUSD-0.39%USDJPY+0.39%NZDCAD-0.39%NZDMXN+0.34%AUDNZD+0.33%EURJPY-0.32%GBPHKD+0.32%EURGBP-0.31%EURSEK+0.31%CHFNOK-0.31%EURCHF+0.29%GBPMXN-0.28%USDTRY+0.28%EURNOK-0.28%CHFSEK+0.28%AUDUSD-0.27%PLNJPY-0.26%USDCAD+0.23%CHFSGD-0.22%NZDJPY-0.21%AUDSGD+0.21%GBPZAR+0.20%GBPNZD+0.19%EURSGD-0.19%USDILS+0.16%CADJPY+0.15%GBPCAD-0.15%AUDNOK+0.13%NZDSGD-0.12%SGDJPY-0.12%AUDJPY+0.11%GBPAUD-0.10%EURNZD-0.09%USDCNH+0.09%EURZAR+0.08%GBPSGD-0.06%EURPLN-0.04%AUDCAD-0.04%USDCOP-0.04%NOKJPY-0.03%EURCZK+0.02%GBPJPY-0.01%USDHKD+0.01%EURDKK+0.01%GAGUSD-4.47%XAGUSD-4.47%COFFEE+2.55%XPTUSD-2.26%XNGUSD-1.69%GAUUSD-1.60%XAUUSD-1.60%SUGAR-1.04%COTTON+0.88%S1-0.66%COCOA+0.63%USOIL+0.57%BTCUSD-0.44%ETHUSD+15.24%USDTUSD-0.01%XRPUSD+9.86%SOLUSD+10.90%TRXUSDT+2.00%ZECUSDT-0.33%DOGEUSD+11.12%XMRUSDT+1.39%LINKUSD+11.09%XLMUSD-2.22%BCHUSDT-0.15%UNIUSD-3.24%LTCUSD+9.37%SUIUSD-2.08%HBARUSDT-1.95%TONUSD+24.80%TAOUSDT-1.60%AAVEUSD-1.53%DOTUSDT-1.83%ICPUSDT-2.15%ONDOUSDT-2.99%WLDUSDT-3.84%ARBUSDT-3.74%JUPUSDT-3.47%ATOMUSDT-3.38%INJUSDT-3.12%STXUSDT-1.71%FETUSDT-1.89%PYTHUSDT+7.07%TIAUSDT-4.39%SEIUSDT-3.09%IMXUSDT-3.65%OPUSDT-9.29%GRTUSDT-2.22%WIFUSDT-2.26%IOTAUSDT-3.83%AXSUSDT-3.30%POLUSDT-3.87%FARTCOINUSDT-3.92%EOSUSDT+5.47%DYDXUSDT-4.30%GALAUSDT-4.04%ORDIUSDT-3.21%RONINUSDT-5.76%NOTUSDT-3.35%NVDA-1.44%AAPL+1.26%GOOGL+0.85%MSFT-0.21%AMZN-0.15%TSM-1.43%SPCX-2.37%META-1.43%AVGO-1.85%TSLA-2.60%LLY+3.76%BRK-B-0.30%SKHY-3.54%MU-1.09%AMD-2.92%WMT+1.78%JPM-0.26%V-0.45%XOM+0.62%ASMLa+1.88%JNJ+0.81%MA-0.10%INTC-1.89%ABBV+2.31%0700.HK-0.42%1398.HK-0.92%CSCO+0.27%CVX+1.02%COST+1.13%KO+0.67%ORCL-6.65%PG+1.14%LRCX-2.85%AMAT-2.50%AP2d+0.04%UNH+3.63%BAC-8.01%DELL-7.35%CAT-1.04%1816.HK+2.71%3988.HK-1.12%0005.HK-1.79%0857.HK+1.17%HSBA.L-1.35%GE+0.47%PM+1.45%0939.HK-1.00%1288.HK-2.23%NFLX+0.41%HD-0.72%USDCHF+1.02%USDSEK+1.00%USDMXN+0.95%CADCHF+0.80%USDZAR+0.76%AUDCHF+0.74%EURUSD-0.71%USDDKK+0.69%EURHKD-0.68%USDPLN+0.64%GBPCHF+0.64%CHFJPY-0.62%EURCNH-0.59%NZDUSD-0.58%USDTHB+0.52%EURCAD-0.50%USDSGD+0.50%EURAUD-0.42%GBPTRY+0.41%AUDDKK+0.41%USDNOK+0.41%NZDCHF+0.41%GBPUSD-0.39%USDJPY+0.39%NZDCAD-0.39%NZDMXN+0.34%AUDNZD+0.33%EURJPY-0.32%GBPHKD+0.32%EURGBP-0.31%EURSEK+0.31%CHFNOK-0.31%EURCHF+0.29%GBPMXN-0.28%USDTRY+0.28%EURNOK-0.28%CHFSEK+0.28%AUDUSD-0.27%PLNJPY-0.26%USDCAD+0.23%CHFSGD-0.22%NZDJPY-0.21%AUDSGD+0.21%GBPZAR+0.20%GBPNZD+0.19%EURSGD-0.19%USDILS+0.16%CADJPY+0.15%GBPCAD-0.15%AUDNOK+0.13%NZDSGD-0.12%SGDJPY-0.12%AUDJPY+0.11%GBPAUD-0.10%EURNZD-0.09%USDCNH+0.09%EURZAR+0.08%GBPSGD-0.06%EURPLN-0.04%AUDCAD-0.04%USDCOP-0.04%NOKJPY-0.03%EURCZK+0.02%GBPJPY-0.01%USDHKD+0.01%EURDKK+0.01%GAGUSD-4.47%XAGUSD-4.47%COFFEE+2.55%XPTUSD-2.26%XNGUSD-1.69%GAUUSD-1.60%XAUUSD-1.60%SUGAR-1.04%COTTON+0.88%S1-0.66%COCOA+0.63%USOIL+0.57%BTCUSD-0.44%ETHUSD+15.24%USDTUSD-0.01%XRPUSD+9.86%SOLUSD+10.90%TRXUSDT+2.00%ZECUSDT-0.33%DOGEUSD+11.12%XMRUSDT+1.39%LINKUSD+11.09%XLMUSD-2.22%BCHUSDT-0.15%UNIUSD-3.24%LTCUSD+9.37%SUIUSD-2.08%HBARUSDT-1.95%TONUSD+24.80%TAOUSDT-1.60%AAVEUSD-1.53%DOTUSDT-1.83%ICPUSDT-2.15%ONDOUSDT-2.99%WLDUSDT-3.84%ARBUSDT-3.74%JUPUSDT-3.47%ATOMUSDT-3.38%INJUSDT-3.12%STXUSDT-1.71%FETUSDT-1.89%PYTHUSDT+7.07%TIAUSDT-4.39%SEIUSDT-3.09%IMXUSDT-3.65%OPUSDT-9.29%GRTUSDT-2.22%WIFUSDT-2.26%IOTAUSDT-3.83%AXSUSDT-3.30%POLUSDT-3.87%FARTCOINUSDT-3.92%EOSUSDT+5.47%DYDXUSDT-4.30%GALAUSDT-4.04%ORDIUSDT-3.21%RONINUSDT-5.76%NOTUSDT-3.35%
BS

BioNTech SE (BNTX)

NASDAQ • Healthcare

$90.03
+$1.01 (+1.1%)
Market open

October 14, 2026 at 13:58 UTC

Open$92.36
Previous Close$89.01
Day Range$88.85 - $93.08
Avg. Volume (3M)952.4K
Market Cap$22.6B
52 Week Range
$79.52$124
Next EarningsIn 20 daysNov 3, 2026

Interactive Chart

13:58:06 UTC

Metrics Over Time

Where the Money Goes

Q2 2026
Revenueeverything earned$105.6M100%
Gross Profitminus cost of goods$8.6M8%

Fundamentals & Financials

Revenue (TTM)
$2.6B
Net Income (TTM)
-$1.6B
EPS (TTM)
-$6.73
ROA (TTM)
-8.34%
Current Ratio
7.85
Dividend Yield
0%

TTM is calculated as the sum of the four most recently completed quarters. This is a standard approach when monthly or real-time data is not available.

Earnings

-556.7%Q1 2026-$1.44
+4.4%Q2 2026-$2.43
-54.3%Q3 2026-$3.7
Next

Nov 3

in 20 daysQ4 2026

% — EPS deviation from the forecast (beat / miss); quarters without a forecast show the reported EPS

Latest report — Q3 2026
Miss -54.3%

BioNTech’s adjusted EPS missed consensus in the second fiscal quarter of 2026, based on preliminary results reported Aug. 4. Adjusted EPS came in at EUR -2.58 versus the EUR -2.40 estimate, about -7.6%, and was down from EUR -1.82 a year earlier. Operating income was a loss of about EUR 752.5 million, while net income fell 115.8% to a loss of about EUR 834.4 million from a loss of EUR 386.6 million a year ago. Operating cash flow was about EUR 11 million. Consensus for the next period calls for EPS of EUR 0.85 and revenue of EUR 1.22 billion.

Next report — what to expect

BioNTech SE (BNTX) reports on November 3, 2026. Wall Street is looking for consensus EPS of EUR 0.838 on consensus revenue of EUR 1.20 billion. For trailing context, revenue fell -59.5% year over year last quarter. BioNTech has beaten EPS in 6 of 8 most recent quarters.

View full earnings history

About BioNTech SE

BioNTech SE (NASDAQ: BNTX) is a biotechnology company focused on immune-based treatments for cancer and infectious disease, spanning oncology programs, infectious-disease immunotherapies, and protein replacement therapies for rare conditions. The company generated EUR 2.8 billion of revenue in FY2025, with principal operations in Mainz, Germany.

Name
BioNTech SE
CEO
Ugur Sahin
Website
www.biontech.com
Industry
Healthcare
Year Founded
2008
Employees
7,807

Today's Snapshot

AI-generated

Yesterday BNTX fell 7.1% to 89.01. BioNTech's BNT113 mRNA cancer trial missed its goal of delaying disease progression.

Trading Volume

Above 10d avg 1.1M

1.9M

vs S&P 500 Today

Strong Underperformance

-7.11%

Updated: October 14, 2026 at 12:30 UTC

BNTX Headlines

BioNTech ends Phase 2 colorectal cancer trial

August 28, 2026

2 min read

DACH-Focused Stock Moves Across Key Sectors

March 21, 2026

5 min read

Markets Swoon as Bitcoin, Tech and Crypto Firms Slide

February 5, 2026

5 min read
View All News

Technical Indicators

0 Buy2 Neutral6 Sell
BNTX displays a broadly bearish profile driven by clear downside momentum and pervasive moving-average pressure, with the stock well below short, medium and long-term averages. Momentum indicators such as a deeply negative CCI and a negative MACD reinforce selling pressure, while ADX shows little trend strength and volatility is moderate. On-balance volume is substantially negative, highlighting distribution, and the price sits below the lower Bollinger band, marking an oversold but technically weak setup. Technical takeaway: Strong Sell — broad-based bearish signals and weak trend with heavy volume-based distribution.
All signals
  • EMA (5 indicators)$94.95 - $98.40
    Sell
  • RSI (14)35.55
    Neutral
  • Stochastic %K (14, 3, 3)31.69
    Neutral
  • MACD Level (12, 26)-1.62
    Sell

Peers & Related Assets

INCYIncyte Corporation
$108.62-2.5%
IBRXImmunityBio, Inc.
$9.8-3.2%
TGTXTG Therapeutics, Inc.
$54.34-1.7%
IOVAIovance Biotherapeutics, Inc.
$14.5-0.4%
XNCRXencor, Inc.
$23.52-6.1%
GMABGenmab A/S
Stay Ahead of the Market

Get premium market insights delivered directly to your inbox.